Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies, AŞ Message Board

spectrollmicro 7 posts  |  Last Activity: Jul 28, 2015 10:35 AM Member since: Jun 6, 2015
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Re-thinking PTX

    by rja37 Jul 25, 2015 11:24 AM
    spectrollmicro spectrollmicro Jul 28, 2015 10:35 AM Flag

    There was no good reason for the selloff. Any that sold this stock have zero understanding of Pernix and what they do.

    Sentiment: Strong Buy

  • Reply to

    picked up more today

    by spectrollmicro Jul 2, 2015 11:45 AM
    spectrollmicro spectrollmicro Jul 2, 2015 12:50 PM Flag

    I continue to be very confident in my investment. As with all investments, I do my own research unlike many who all they know is the stock symbol.

    By the way I added even more @ $1.30 and believe the vote for the boards recommendations will be a great move. The fact Prima has other partners in their drug development program speaks volumes.

    Sentiment: Strong Buy

  • spectrollmicro by spectrollmicro Jul 2, 2015 11:45 AM Flag

    Just added 28000 at $1.32 too low to pass. CVac is a winner vaccine against cancer, especially ovarian cancer, but much more as well. Find it hard to imagine the type of person that would work to destroy a company engaged in saving lives through cancer research.

    Sentiment: Strong Buy

  • Reply to

    Aug 20th will be end of the 12th week

    by huggmee2005 Jun 30, 2015 12:21 PM
    spectrollmicro spectrollmicro Jun 30, 2015 2:04 PM Flag

    Cramer knows so little about so much. Xoma and Servier scientist have a good handle on drug efficacy and the science. Also the fact FDA granted Orphan drug status to Xoma 358 as a plus to XOMA's efforts is worth mentioning

    Sentiment: Strong Buy

  • Reply to

    Milestones

    by oddusual Jun 12, 2015 12:46 PM
    spectrollmicro spectrollmicro Jun 12, 2015 1:07 PM Flag

    Geron has not specified what triggers the milestones or their specific amounts per trigger, however it would make sense that getting "orphan drug status" would be a trigger, as will start of the next clinical.

    Sentiment: Strong Buy

  • Reply to

    Response Rate 15% vs. 50%

    by alved Jun 12, 2015 9:49 AM
    spectrollmicro spectrollmicro Jun 12, 2015 1:01 PM Flag

    If the press release needs to be explained to someone that is convinced it is a bad report, they don't understand what the report says. When the abstract details are released they will not have their mind changed because they can't see anything other than their perception or their interpretation right or wrong.

    Probably the real reason is it doesn't fit their narrative so therefore they maintain their position regardless.

    Sentiment: Strong Buy

  • spectrollmicro by spectrollmicro Jun 6, 2015 8:58 PM Flag

    With the Phase 3 clinical & good indications a partner is the very least that could be in the works. SInce MEI has do debt, low float, low price, pipeline and drug going into phase 3 and $65 + million in cash a takeover has to be considered. Because Pracinostat in combination with Azacitidine provides high rate and rapid onset of remission of AML patients, it makes me thinks a company familiar is most likely.

    Will have to stay tuned in to see how this plays out. I have invested accordingly in MEIP

    Sentiment: Strong Buy

SIGA
0.00(0.00%)